📊 Score Breakdown
Offering Ability
60
Cash Runway
40
Float Risk
45
Warrant Exposure
15
Convertible Debt—
🌦️ Dilution Forecast
🌥️
Advisory
Moderate dilution signals present
31%
📉 Score Deterioration
40%
• Score rose 29 points recently (worsening)
💰 Capital Raise
38%
• Active shelf registration ($9M, 10% of market cap)
• Active ATM program with $11M remaining capacity
💹 Market Data
Market Cap$94.70M
Shares Outstanding9.01M
Float4.74M
Cash$8.36M
Debt$9.08M
Short InterestN/A
🏛 Institutional Holdings
QoQ: ↑ 9.0% shares (2025Q4 vs prior)
42 institutional holders · 2.06M shares
#1
EcoR1 Capital, LLC
573.2K shares
#2
Redmile Group, LLC
441.7K shares
#3
VANGUARD GROUP INC
225.9K shares
+ 17 more holders Sign up free to view →
📉 Short Interest
Short Interest546.5K
Days to Cover1.0
% of Float11.5%
FINRA data as of May 15, 2026
📁 Recent SEC Activity
xbrl
XBRL CONVERTIBLE
Dec 31, 2014
EFFECT
EFFECT
Mar 25, 2026
424B3
ATM
Mar 25, 2026
4
INSIDER TRANSACTION
Mar 19, 2026
S-3
SHELF
Mar 17, 2026
Full SEC filing analysis available with free account →
📰 Recent News
No recent news
🔬 More Research for ATRA
📊 ATRA FDA Catalyst Timeline & Biotech Grade — BiotechSigns
📡 ATRA Signal Convergence & Dark Pool Activity — StonkWhisper
Part of the Guerilla Finance research network. Cross-reference multiple data sources for better due diligence.